EOLS CIK: 1570562

Evolus, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
56.1
FY22:
89.8
FY23:
138
FY24:
182
FY25:
197
(positive)
Change from FY21 to FY25
millions USD
FY21:
−44.4
FY22:
−6.49
FY23:
15.3
FY24:
49.6
FY25:
67.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−46.8
FY22:
−74.3
FY23:
−61.5
FY24:
−49.8
FY25:
−51.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−46.8
FY22:
−74.4
FY23:
−61.7
FY24:
−50.4
FY25:
−51.6

All amounts in millions USD Data source:SEC EDGAR